Tom PIT Studio - platform for designing information systems

Projektinformationen

Tom PIT Studio

ID Finanzhilfevereinbarung: 728860

DOI 10.3030/728860

Projekt abgeschlossen

EK-Unterschriftsdatum 13 Mai 2016

Startdatum 1 Juni 2016

Enddatum 31 Oktober 2016

Finanziert unter

• INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)

Gesamtkosten € 71 429,00

EU-Beitrag € 50 000,00

Koordiniert durch

TOM PIT RAZVOJ PROGRAMSKE OPREME DOO
Slovenia

Ziel

Pharmaceutical sector demands information systems (IS) to be custom designed and in compliance with Good manufacturing practice (GMP) regulative. In addition IS must be build according to Food and Drug Administration (FDA) regulative CFR Part 11 . This is currently a big problem for all IS providers which are cooperating with pharmaceutical sector because the effort made to achieve this is substantial, time consuming and expensive. The price of such validated system can be three times as high as with similar non-validated system. We can attribute this to programming methods which are not agile enough. With the proposed project we want to introduce, first to EU and then global markets, an innovative solution to address above mentioned challenges - Tom PIT Studio (TPS). TPS introduces unique modeling method of developing IS which reduces development time by 70% and lowers maintenance cost by 90%. Demand for such a product comes from all pharmaceutical companies with a potential in other industries as well. Product is therefore not limited to local (EU) market but has is a great global potential (Asia, USA) estimated at 7 billion €. Product is developed to TRL6 level and is already being used for demonstrational purposes as well as evaluation with SME and pharmaceutical companies in our geographical region. Plan is to develop product to TRL 9 and assure fast market up take. Feasibility study is critical for us to further elaborate commercialization strategy in order to access global market. TPS is a great business opportunity for us but also has bigger impact on EU economy as it provides leverage for SME IT companies to enter market currently controlled by big IT vendors with their own competitive solution thereby widening offer of information systems and consequently lowering implementation costs for pharmaceutical companies.

Wissenschaftliches Gebiet

• engineering and technology › other engineering and technologies › food technology
• natural sciences › computer and information sciences › internet › internet of things
• natural sciences › computer and information sciences › software
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs
• natural sciences › computer and information sciences › data science › big data

Programm/Programme

• H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT) Main Programme
• H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument

Thema/Themen

• SMEInst-01-2016-2017 - Open Disruptive Innovation Scheme

Aufforderung zur Vorschlagseinreichung

H2020-SMEInst-2016-2017

Andere Projekte für diesen Aufruf anzeigen

Unterauftrag

H2020-SMEINST-1-2016-2017

Finanzierungsplan

SME-1 - SME instrument phase 1

Koordinator

TOM PIT RAZVOJ PROGRAMSKE OPREME DOO

• Netto-EU-Beitrag: € 50 000,00
• Adresse: RIPSLOVA ULICA 7 ; 3230 SENTJUR ; Slowenien
• KMU Die Organisation definierte sich zum Zeitpunkt der Unterzeichnung der Finanzhilfevereinbarung selbst als KMU (Kleine und mittlere Unternehmen). Ja:
  Region
  Slovenija › Vzhodna Slovenija › Savinjska
• Region: Slovenija › Vzhodna Slovenija › Savinjska
• Aktivitätstyp: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Gesamtkosten: € 71 429,00